Author:
Härtel Nicolai,Klautke Gunther,Ronellenfitsch Ulrich
Publisher
Springer Berlin Heidelberg
Reference85 articles.
1. Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L, Poston GJ, Wicherts DA, de Haas RJ (2010) Liver resection of colorectal metastases in elderly patients. Br J Surg 97(3):366–376. https://doi.org/10.1002/bjs.6889
2. Andre T (2017a) Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 study. J Clin Oncol 35 (suppl; abstr 3531)
3. Andre T (2017b) Three versus six months adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer: the French participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project. J Clin Oncol 35 (suppl; abstr 3500)
4. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351. https://doi.org/10.1056/NEJMoa032709350/23/2343
5. Aparicio T, Gargot D, Teillet L, Maillard E, Genet D, Cretin J, Locher C, Bouche O, Breysacher G, Seitz JF, Gasmi M, Stefani L, Ramdani M, Lecomte T, Auby D, Faroux R, Bachet JB, Lepere C, Khemissa F, Sobhani I, Boulat O, Mitry E, Jouve JL (2017) Geriatric factors analyses from FFCD 2001–02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients. Eur J Cancer 74:98–108. https://doi.org/10.1016/j.ejca.2016.09.029 , [pii] S0959-8049(16)32475-3